From: Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients
ME-Liquidchip vs Sanger sequencing | Â | Â | Â | ME-Liquidchip vs Pyrosequencing | Â | Â | Â | Sanger sequencing vs Pyrosequencing | Â | Â | Â |
---|---|---|---|---|---|---|---|---|---|---|---|
ME-Liquidchip | Â | Â | Â | ME-Liquidchip | Â | Â | Â | Sanger sequencing | Â | Â | Â |
Sanger sequencing | WT | Mut | Total | Pyrosequencing | WT | Mut | Total | Pyrosequencing | WT | Mut | Total |
WT | 94 | 5 | 99 | WT | 94 | 6 | 100 | WT | 99 | 1 | 100 |
Mut | 0 | 7 | 7 | Mut | 0 | 6 | 6 | Mut | 0 | 6 | 6 |
Total | 94 | 12 | 106 | Total | 94 | 12 | 106 | Total | 99 | 7 | 106 |